Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
about
Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.Fragment-based strategy for structural optimization in combination with 3D-QSAR.PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.c-MET kinase inhibitors: a patent review (2011 - 2013).Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.Pharmacophore Mapping Approach for Drug Target Identification: A Chemical Synthesis and in Silico Study on Novel Thiadiazole Compounds.Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain.An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist.Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes.The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase.Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.Exploring c-Met kinase flexibility by sampling and clustering its conformational space.
P2860
Q33635671-6EFBC232-0B44-4F06-A8F6-56D8B8110BDAQ33830522-4627798A-A05A-4156-BCB8-4B62C75C7774Q35030073-26B1318C-180C-4F2D-81BB-8450573E32A1Q37376230-E7B4D655-6A08-4F10-807D-E6E5ED75D6D4Q38165247-FD592A6C-9640-46BA-A436-69468FA15581Q38431115-F3B66C05-06CE-43DF-B3F8-ACE0CE02E2C5Q38704262-128C6F3F-CA51-4254-A8E2-22F4B26B8979Q38989374-82EA5F9E-6EA6-4075-AB35-09C5E9F58FB1Q39628474-B7372DF5-D9BB-4CBC-A373-325F8523198BQ42088207-6DDEB190-32A5-45D6-93D2-4CDC0F39898CQ45332740-AFD865E3-D07D-4485-BEA0-81672A8F0B48Q46659031-8AACFAFF-0F30-4EC9-A946-DB63271C2978Q46888149-DC710060-DA81-40A5-99C9-F40C6AE75498Q51438298-D4B329EC-0773-4B61-94D4-54C721E46BB1
P2860
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@ast
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@en
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@nl
type
label
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@ast
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@en
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@nl
prefLabel
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@ast
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@en
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
@nl
P2093
P2860
P3181
P356
P1476
Structural basis for selective small molecule kinase inhibition of activated c-Met
@en
P2093
David J Guerin
Dawn L Hall
Elizabeth F Stanton
Jennifer M Shipman
John C Reid
Jonathon R Young
Keith W Rickert
Kevin J Wilson
Maria Kornienko
P2860
P304
11218-11225
P3181
P356
10.1074/JBC.M110.204404
P407
P50
P577
2011-01-18T00:00:00Z